埃索美拉唑肠溶胶囊治疗十二指肠溃疡的疗效和安全性观察
Efficacy and safety of esomeprazole enteric coated capsules in the treatment of duodenal ulcer
祝颂 1周海港 1李宗双1
作者信息
- 1. 嵊泗县人民医院 内二科,浙江 舟山 202450
- 折叠
摘要
目的 观察埃索美拉唑肠溶胶囊治疗十二指肠溃疡的疗效和安全性.方法 选取嵊泗县人民医院收治的十二指肠溃疡患者52例,随机均分为观察组和对照组,每组26例.对照组采用奥美拉唑进行治疗,观察组采用埃索美拉唑肠溶胶囊治疗,对2组的治疗效果和安全性进行比较.结果 观察组患者的幽门螺杆菌根除率为96.15%(25/26),明显高于对照组的80.76%(21/26)(P<0.05),且观察组患者的临床疗效更佳,没有严重的不良反应出现.结论 对十二指肠溃疡患者采用埃索美拉唑肠溶胶囊治疗效果显著,能够有效地帮助患者改善症状,清除体内的幽门杆菌,且无严重不良反应出现,安全性高,利于患者的身体恢复.
Abstract
Objective To observe the efficacy and safety of esomeprazole enteric coated capsules in the treatment of duodenal ulcer.Methods52 cases of duodenal ulcer were selected and randomly divided into the observation group and the control group, 26 cases in each group.The control group was treated with omeprazole, the observation group was treated with esomeprazole enteric coated capsules, and the therapeutic effects of the two groups were evaluated.ResultsThe eradication rate of Helicobacter pylori in the observation group was 96.15% (25/26),which was significantly higher than the control group 80.76%(21/26)(P<0.05), and the clinical efficacy was better, had no serious adverse reactions.ConclusionEsomeprazole enteric coated capsules, can effectively help improve the symptoms of patients with duodenal ulcer, remove the Helicobacter pylori, and no serious adverse reaction, high safety.
关键词
十二指肠溃疡/埃索美拉唑肠溶胶囊/临床疗效Key words
duodenal ulcer/Esomeprazole enteric coated capsules/clinical efficacy引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据